Kintor Pharmaceutical Limited
HKEX:9939.HK
1.13 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||
Current Assets: | ||||||||||
Cash & Cash Equivalents
| 445.499 | 0.865 | 0.93 | 1.066 | 0.196 | 0.138 | 13.193 | 9.64 | 25.693 | 2.017 |
Short Term Investments
| 10 | 0.012 | 0.127 | 0.328 | 0.001 | 0.001 | 16 | 0 | 11 | 10 |
Cash and Short Term Investments
| 455.499 | 0.877 | 1.057 | 1.393 | 0.197 | 0.138 | 29.193 | 9.64 | 36.693 | 12.017 |
Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0.641 | 0.284 | 0 | 0 |
Inventory
| 0 | 0.604 | 0.351 | 0 | 0 | 0 | -0 | 0.15 | 0 | 0 |
Other Current Assets
| 0.015 | 0.027 | 0.118 | 0.027 | 0.024 | 0.08 | 4.926 | 2.981 | 1.582 | 0.489 |
Total Current Assets
| 472.557 | 1.508 | 1.526 | 1.421 | 0.221 | 0.218 | 34.76 | 13.055 | 38.275 | 12.507 |
Non-Current Assets: | ||||||||||
Property, Plant & Equipment, Net
| 190.713 | 0.282 | 0.262 | 0.187 | 0.113 | 0.023 | 4.202 | 3.883 | 1.813 | 0.923 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 180.07 | 0.236 | 0.236 | 0.21 | 0.179 | 0.172 | 9.817 | 0.004 | 0.005 | 0.005 |
Goodwill and Intangible Assets
| 180.07 | 0.236 | 0.236 | 0.21 | 0.179 | 0.172 | 9.817 | 0.004 | 0.005 | 0.005 |
Long Term Investments
| 0.018 | 0.018 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 25.866 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0.008 | -0.536 | 0 | -0.396 | -0.292 | -0.196 | 0.357 | 0.007 | 0.021 | 0.011 |
Total Non-Current Assets
| 396.675 | 0.536 | 0.498 | 0.396 | 0.292 | 0.196 | 14.376 | 3.895 | 1.839 | 0.939 |
Total Assets
| 869.232 | 2.055 | 2.068 | 1.851 | 0.553 | 0.424 | 49.136 | 16.95 | 40.114 | 13.445 |
Liabilities & Equity: | ||||||||||
Current Liabilities: | ||||||||||
Account Payables
| 68.288 | 0.18 | 0.173 | 0.029 | 0.023 | 0.007 | 0 | 0 | 0 | 0 |
Short Term Debt
| 118.23 | 103.335 | 9.469 | 86.313 | 61.786 | 44.926 | 15 | 0 | 0 | 0 |
Tax Payables
| 0.432 | 1.899 | 2.097 | 1.179 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 38.183 | -103.335 | -9.469 | -86.313 | -61.786 | -44.926 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 0.029 | 0.138 | 0.047 | 0.141 | 0.119 | 0.101 | 0.505 | 0.1 | 0.389 | 0.397 |
Total Current Liabilities
| 224.73 | 0.318 | 0.22 | 0.169 | 0.143 | 0.108 | 15.505 | 0.1 | 0.389 | 0.397 |
Non-Current Liabilities: | ||||||||||
Long Term Debt
| 135.69 | 0.178 | 0.148 | 0.135 | 2.311 | 0.022 | 30 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 19.657 | 19.952 | 4.009 | -38.683 | -0.039 | -38.796 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 31.043 | 38.818 | 38.818 | 38.818 | 38.818 | 38.818 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | -58.77 | -42.827 | -0.135 | 0.039 | -0.022 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 186.39 | 0.178 | 0.148 | 0.135 | 41.129 | 0.022 | 30 | 0 | 0 | 0 |
Total Liabilities
| 411.12 | 0.56 | 0.413 | 0.344 | 0.184 | 0.172 | 45.505 | 0.1 | 0.389 | 0.397 |
Equity: | ||||||||||
Preferred Stock
| 3,784.664 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 0.315 | 0 | 0 | 0 | 0 | 0.017 | 19.655 | 18.781 | 18.781 | 16.074 |
Retained Earnings
| -3,784.664 | -2.724 | -1.769 | -0.927 | -0.419 | -0.187 | -104.087 | -57.87 | -32.393 | -20.952 |
Accumulated Other Comprehensive Income/Loss
| 0.458 | 0.115 | 0.065 | 2.435 | 0.789 | 421.494 | 0 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 457.339 | 4.104 | 3.359 | 0 | 0 | -421.073 | 88.062 | 55.939 | 53.337 | 17.926 |
Total Shareholders Equity
| 458.112 | 1.495 | 1.655 | 1.508 | 0.37 | 0.252 | 3.631 | 16.849 | 39.725 | 13.048 |
Total Equity
| 458.112 | 1.495 | 1.655 | 1.508 | 0.37 | 0.252 | 3.631 | 16.849 | 39.725 | 13.048 |
Total Liabilities & Shareholders Equity
| 869.232 | 2,055.136 | 2,067.989 | 1,851.475 | 553.376 | 423.597 | 49.136 | 16.95 | 40.114 | 13.445 |